Sensus Healthcare, Inc.

Quarterly Report for period ending 2023-09-30

Quarterly Report for period ending 2023-06-30

Quarterly Report for period ending 2023-03-31

Annual Report for period ending 2022-12-31

Quarterly Report for period ending 2022-09-30

Quarterly Report for period ending 2022-06-30

Quarterly Report for period ending 2022-03-31

Annual Report for period ending 2021-12-31

Quarterly Report for period ending 2021-09-30

Quarterly Report for period ending 2021-06-30

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Current report filing

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

Notice of Effectiveness

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Order Granting Confidential Treatment

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

Order Granting Confidential Treatment

Solot Edwin Lee: Major Shareholders

Sardano Michael: Statement of changes in beneficial ownership of securities

Martinez Magdalena: Statement of changes in beneficial ownership of securities

Sardano Joseph C: Statement of changes in beneficial ownership of securities

Sardano Michael: Statement of changes in beneficial ownership of securities

Sardano Michael: Statement of changes in beneficial ownership of securities

Sardano Joseph C: Statement of changes in beneficial ownership of securities

Rampolla Javier: Statement of changes in beneficial ownership of securities

Heinrich John: Statement of changes in beneficial ownership of securities

Sardano Joseph C: Statement of changes in beneficial ownership of securities

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Prospectus filed pursuant to Rule 424(b)(3)

Prospectus filed pursuant to Rule 424(b)(5)

Prospectus filed pursuant to Rule 424(b)(2)

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Registration statement for specified transactions by certain issuers

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Prospectus filed pursuant to Rule 424(b)(4)

A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1

General form of registration statement for all companies including face-amount certificate companies

Definitive proxy statements

Preliminary proxy statement not related to a contested matter or merger/acquisition

Definitive proxy statements

Definitive proxy statements

Definitive revised proxy soliciting materials

Definitive proxy statements

Definitive proxy statements

Definitive proxy statements

Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.

Definitive proxy statements